
Press Release December 19, 2022
PMPRB Delay
an Opportunity for Meaningful Consultation
Ottawa, ON – Innovative Medicines Canada (IMC) welcomes the Patented Medicine Prices Review Board (PMPRB) announcement to delay the implementation […]